Hydroxymethyl-N-methylpiperidine is used in the preparation of pyrimidines as FGFR3 tyrosine kinase inhibitors as well as for potent pyrazine c-Src inhibitors in the treatment of ischemic stroke.
参考文献
Mukaiyama, H. et al.: Bioorg. Med. Chem., 15, 868 (2007); Le Corre, L. et al.: Org. Biomol. Chem., 8, 2164 (2010);
沪ICP备17019645号
400-821-0725
